Apex Biotechnology Corp (1733) — Capital Reinvestment Ratio
Latest as of September 2025:
0.57x
Apex Biotechnology Corp (1733) has a Capital Reinvestment Ratio of 0.57x as of September 2025, meaning it reinvests 1% of its operating cash flow (NT$5.19 Million) in capital expenditures (NT$2.97 Million). See Apex Biotechnology Corp (1733) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.57x
Capex / Operating Cash Flow
Operating Cash Flow
NT$5.19 Million
TWD
Capital Expenditures
NT$2.97 Million
TWD
Data as of
Sep 2025
Most recent filing
Apex Biotechnology Corp Capital Reinvestment Ratio (2002–2024)
This chart tracks Apex Biotechnology Corp's Capital Reinvestment Ratio across 23 annual periods.
Annual Capital Reinvestment Ratio for Apex Biotechnology Corp (2002–2024)
Year-by-year Capital Reinvestment Ratio for Apex Biotechnology Corp from 2002 to 2024. For live market cap and broader valuation context, see Apex Biotechnology Corp stock valuation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | NT$328.67 Million | NT$29.63 Million | ▼ -16.8% |
| 2023 | 0.11x | NT$230.39 Million | NT$24.98 Million | ▼ -92.8% |
| 2022 | 1.51x | NT$26.62 Million | NT$40.20 Million | ▲ +936.9% |
| 2021 | 0.15x | NT$179.87 Million | NT$26.20 Million | ▼ -15.4% |
| 2020 | 0.17x | NT$280.60 Million | NT$48.32 Million | ▲ +40.8% |
| 2019 | 0.12x | NT$462.52 Million | NT$56.58 Million | ▼ -89.0% |
| 2018 | 1.11x | NT$67.57 Million | NT$75.29 Million | ▲ +194.9% |
| 2017 | 0.38x | NT$70.83 Million | NT$26.76 Million | ▲ +192.8% |
| 2016 | 0.13x | NT$298.06 Million | NT$38.45 Million | ▲ +128.5% |
| 2015 | 0.06x | NT$472.15 Million | NT$26.66 Million | ▼ -76.9% |
| 2014 | 0.24x | NT$267.60 Million | NT$65.41 Million | ▼ -52.2% |
| 2013 | 0.51x | NT$484.77 Million | NT$247.69 Million | ▼ -37.2% |
| 2012 | 0.81x | NT$509.67 Million | NT$414.70 Million | ▲ +198.1% |
| 2011 | 0.27x | NT$273.45 Million | NT$74.63 Million | ▼ -21.1% |
| 2010 | 0.35x | NT$465.59 Million | NT$161.05 Million | ▲ +84.6% |
| 2009 | 0.19x | NT$391.29 Million | NT$73.34 Million | ▼ -56.7% |
| 2008 | 0.43x | NT$299.96 Million | NT$129.74 Million | ▲ +188.3% |
| 2007 | 0.15x | NT$364.62 Million | NT$54.71 Million | ▲ +30.0% |
| 2006 | 0.12x | NT$363.71 Million | NT$41.99 Million | ▼ -69.9% |
| 2005 | 0.38x | NT$212.14 Million | NT$81.30 Million | ▼ -66.7% |
| 2004 | 1.15x | NT$218.54 Million | NT$251.16 Million | ▲ +518.0% |
| 2003 | 0.19x | NT$302.25 Million | NT$56.21 Million | ▼ -75.8% |
| 2002 | 0.77x | NT$79.49 Million | NT$61.13 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow